AI
Allostery Investments Portfolio holdings
AUM
$7.85M
This Quarter Return
-2.75%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$69.3M
AUM Growth
+$18.4M
(+36%)
Cap. Flow
+$22.4M
Cap. Flow
% of AUM
32.32%
Top 10 Holdings %
Top 10 Hldgs %
65.25%
Holding
55
New
16
Increased
11
Reduced
5
Closed
5
Top Buys
| 1 |
Merus
MRUS
|
+$4.33M |
| 2 |
ABVX
Abivax
ABVX
|
+$3.18M |
| 3 |
BridgeBio Pharma
BBIO
|
+$2.77M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$2.32M |
| 5 |
Beam Therapeutics
BEAM
|
+$1.81M |
Top Sells
| 1 |
Ionis Pharmaceuticals
IONS
|
+$905K |
| 2 |
MindMed
MNMD
|
+$905K |
| 3 |
Dianthus Therapeutics
DNTH
|
+$545K |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
+$496K |
| 5 |
Jasper Therapeutics
JSPR
|
+$470K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Invesco QQQ Trust
QQQ
$373B
| – | – |
0
| – | – |
|
52
TG Therapeutics
TGTX
$5.1B
| – | – |
0
| – | – |
|
53
iShares 20+ Year Treasury Bond ETF
TLT
$49.6B
| – | – |
0
| – | – |
|
54
Viridian Therapeutics
VRDN
$1.54B
| – | – |
0
| – | – |
|
55
SPDR S&P Biotech ETF
XBI
$5.43B
| – | – |
0
| – | – |
|